Lady A’s Charles Kelley details sobriety journey

The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled…

A new antibiotic compound could help treat a bacterium the World Health Organization classes as a major threat.

Dr Will Welfare, UKHSA Incident Director, said: “This is the first time we have detected this virus in humans in the UK. As soon as we get such a result, we immediately start work with partners to learn everything we can about it. Our investigation is continuing at pace and we will publish further information…

As weight-loss medications like Ozempic and Wegovy peak in popularity moving into the New Year, semaglutide experts believe these meds could make it more likely that people will stick with their resolutions. (SEBASTIEN BOZON/AFP via Getty Images) STICKING WITH IT – Ozempic and other weight-loss drugs may strengthen New Year’s resolutions, experts say. Continue reading……

Business & FinanceDealsHealth 23 August 2023, 2:10 pm 1 minute Reuters exclusively reported that NextGen Healthcare (NXGN.O), a provider of software that helps manage patients’ records, is exploring options that include a sale of the company.  Market Impact NextGen shares rose 10% to $18.01 on the news in afternoon trading in New York on Wednesday,…

Shares of Walgreens closed 5% lower on Thursday after the company reported fiscal first-quarter adjusted earnings and revenue that topped expectations, but cut its quarterly dividend nearly in half.  The retail pharmacy giant slashed its dividend to 25 cents per share from 48 cents per share to “strengthen [its] long-term balance sheet and cash position,” CEO…